Correlation Between Collegium Pharmaceutical and Dynavax Technologies
Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collegium Pharmaceutical and Dynavax Technologies, you can compare the effects of market volatilities on Collegium Pharmaceutical and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Dynavax Technologies.
Diversification Opportunities for Collegium Pharmaceutical and Dynavax Technologies
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Collegium and Dynavax is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Dynavax Technologies go up and down completely randomly.
Pair Corralation between Collegium Pharmaceutical and Dynavax Technologies
Given the investment horizon of 90 days Collegium Pharmaceutical is expected to under-perform the Dynavax Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Collegium Pharmaceutical is 1.45 times less risky than Dynavax Technologies. The stock trades about -0.29 of its potential returns per unit of risk. The Dynavax Technologies is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 1,087 in Dynavax Technologies on August 24, 2024 and sell it today you would earn a total of 149.00 from holding Dynavax Technologies or generate 13.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Collegium Pharmaceutical vs. Dynavax Technologies
Performance |
| Timeline |
| Collegium Pharmaceutical |
| Dynavax Technologies |
Collegium Pharmaceutical and Dynavax Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Collegium Pharmaceutical and Dynavax Technologies
The main advantage of trading using opposite Collegium Pharmaceutical and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.| Collegium Pharmaceutical vs. Phibro Animal Health | Collegium Pharmaceutical vs. ANI Pharmaceuticals | Collegium Pharmaceutical vs. Procaps Group SA | Collegium Pharmaceutical vs. Amphastar P |
| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |